Literature DB >> 17616680

Born to be exported: COOH-terminal nuclear export signals of different strength ensure cytoplasmic accumulation of nucleophosmin leukemic mutants.

Niccolò Bolli1, Ildo Nicoletti, M Felicetta De Marco, Barbara Bigerna, Alessandra Pucciarini, Roberta Mannucci, Maria Paola Martelli, Arcangelo Liso, Cristina Mecucci, Francesco Fabbiano, Massimo F Martelli, Beric R Henderson, Brunangelo Falini.   

Abstract

Creation of a nuclear export signal (NES) motif and loss of tryptophans (W) 288 and 290 (or 290 only) at the COOH terminus of nucleophosmin (NPM) are both crucial for NPM aberrant cytoplasmic accumulation in acute myelogenous leukemia (AML) carrying NPM1 mutations. Hereby, we clarify how these COOH-terminal alterations functionally cooperate to delocalize NPM to the cytoplasm. Using a Rev(1.4)-based shuttling assay, we measured the nuclear export efficiency of six different COOH-terminal NES motifs identified in NPM mutants and found significant strength variability, the strongest NES motifs being associated with NPM mutants retaining W288. When artificially coupled with a weak NES, W288-retaining NPM mutants are not exported efficiently into cytoplasm because the force (W288) driving the mutants toward the nucleolus overwhelms the force (NES) exporting the mutants into cytoplasm. We then used this functional assay to study the physiologic NH(2)-terminal NES motifs of wild-type NPM and found that they are weak, which explains the prominent nucleolar localization of wild-type NPM. Thus, the opposing balance of forces (tryptophans and NES) seems to determine the subcellular localization of NPM. The fact that W288-retaining mutants always combine with the strongest NES reveals mutational selective pressure toward efficient export into cytoplasm, pointing to this event as critical for leukemogenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17616680     DOI: 10.1158/0008-5472.CAN-07-0273

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  32 in total

1.  Histone chaperones link histone nuclear import and chromatin assembly.

Authors:  Kristin M Keck; Lucy F Pemberton
Journal:  Biochim Biophys Acta       Date:  2011-10-08

Review 2.  Nucleophosmin (NPM1) mutations in adult and childhood acute myeloid leukaemia: towards definition of a new leukaemia entity.

Authors:  Rachel Rau; Patrick Brown
Journal:  Hematol Oncol       Date:  2009-12       Impact factor: 5.271

Review 3.  Nucleophosmin mutations in acute myeloid leukemia: a tale of protein unfolding and mislocalization.

Authors:  Luca Federici; Brunangelo Falini
Journal:  Protein Sci       Date:  2013-03-18       Impact factor: 6.725

4.  A cellular reporter to evaluate CRM1 nuclear export activity: functional analysis of the cancer-related mutant E571K.

Authors:  Iraia García-Santisteban; Igor Arregi; Marián Alonso-Mariño; María A Urbaneja; Juan J Garcia-Vallejo; Sonia Bañuelos; Jose A Rodríguez
Journal:  Cell Mol Life Sci       Date:  2016-06-16       Impact factor: 9.261

5.  Expression of the cytoplasmic NPM1 mutant (NPMc+) causes the expansion of hematopoietic cells in zebrafish.

Authors:  Niccolò Bolli; Elspeth M Payne; Clemens Grabher; Jeong-Soo Lee; Adam B Johnston; Brunangelo Falini; John P Kanki; A Thomas Look
Journal:  Blood       Date:  2010-03-02       Impact factor: 22.113

Review 6.  Biological and clinical consequences of NPM1 mutations in AML.

Authors:  E M Heath; S M Chan; M D Minden; T Murphy; L I Shlush; A D Schimmer
Journal:  Leukemia       Date:  2017-01-23       Impact factor: 11.528

7.  NPMc+ cooperates with Flt3/ITD mutations to cause acute leukemia recapitulating human disease.

Authors:  Rachel Rau; Daniel Magoon; Sarah Greenblatt; Li Li; Colleen Annesley; Amy S Duffield; David Huso; Emily McIntyre; John G Clohessy; Markus Reschke; Pier Paolo Pandolfi; Donald Small; Patrick Brown
Journal:  Exp Hematol       Date:  2013-10-29       Impact factor: 3.084

8.  Mutant NPM1 Maintains the Leukemic State through HOX Expression.

Authors:  Lorenzo Brunetti; Michael C Gundry; Daniele Sorcini; Anna G Guzman; Yung-Hsin Huang; Raghav Ramabadran; Ilaria Gionfriddo; Federica Mezzasoma; Francesca Milano; Behnam Nabet; Dennis L Buckley; Steven M Kornblau; Charles Y Lin; Paolo Sportoletti; Maria Paola Martelli; Brunangelo Falini; Margaret A Goodell
Journal:  Cancer Cell       Date:  2018-09-10       Impact factor: 31.743

9.  Regulation of subcellular distribution and oncogenic potential of nucleophosmin by plakoglobin.

Authors:  L Lam; Z Aktary; M Bishay; C Werkman; C-Y Kuo; M Heacock; N Srivastava; J R Mackey; M Pasdar
Journal:  Oncogenesis       Date:  2012-03-19       Impact factor: 7.485

10.  Nucleophosmin mutations alter its nucleolar localization by impairing G-quadruplex binding at ribosomal DNA.

Authors:  Sara Chiarella; Antonella De Cola; Giovanni Luca Scaglione; Erminia Carletti; Vincenzo Graziano; Daniela Barcaroli; Carlo Lo Sterzo; Adele Di Matteo; Carmine Di Ilio; Brunangelo Falini; Alessandro Arcovito; Vincenzo De Laurenzi; Luca Federici
Journal:  Nucleic Acids Res       Date:  2013-01-16       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.